Selenium supplementation and secondary prevention of nonmelanoma skin cancer in a randomized trial

Journal of the National Cancer Institute

Volumn 95, Issue 19, 2003, Pages 1477-1481

  Duffield Lillico, Anna J ^a   Slate, Elizabeth H ^b   Reid, Mary E ^c   Turnbull, Bruce W ^d   Wilkins, Patricia A ^e   Combs Jr , Gerald F ^f   Park, H Kim ^g   Gross, Earl G ^h   Graham, Gloria F ⁱ   Stratton, M Suzanne ^e   Marshall, James R ^c   Clark, Larry C ^j  

^a MEMORIAL SLOAN KETTERING CANCER CENTER   (United States)

^b MEDICAL UNIVERSITY OF SOUTH CAROLINA   (United States)

^c ROSWELL PARK CANCER INSTITUTE   (United States)

^d Cornell University   (United States)

^e UNIVERSITY OF ARIZONA   (United States)

^f GRAND FORKS HUMAN NUTRITION RESEARCH CENTER   (United States)

^g Eastern Dermatology and Pathology   (United States)

^h Medical Park Center   (United States)

ⁱ WAKE FOREST BAPTIST HEALTH   (United States)

^j NONE

more..

Author keywords

[No Author keywords available]

Indexed keywords

SELENIUM; ANTINEOPLASTIC AGENT;

ADULT; AGED; ANTINEOPLASTIC ACTIVITY; ARTICLE; BASAL CELL CARCINOMA; CANCER DIAGNOSIS; CANCER INCIDENCE; CANCER PREVENTION; CANCER RISK; CLINICAL TRIAL; DIET SUPPLEMENTATION; DRUG EFFICACY; FEMALE; HUMAN; MALE; MULTIPLE CANCER; PRIORITY JOURNAL; SECONDARY PREVENTION; SKIN CANCER; SQUAMOUS CELL CARCINOMA; STATISTICAL SIGNIFICANCE; UNITED STATES; YEAST; BLOOD; CHEMICALLY INDUCED DISORDER; CONTROLLED CLINICAL TRIAL; CONTROLLED STUDY; DOUBLE BLIND PROCEDURE; INCIDENCE; MIDDLE AGED; MULTICENTER STUDY; RANDOMIZED CONTROLLED TRIAL; RISK; RISK FACTOR; SKIN TUMOR; TREATMENT FAILURE;

ADULT; AGED; ANTINEOPLASTIC AGENTS; CARCINOMA, BASAL CELL; CARCINOMA, SQUAMOUS CELL; DIETARY SUPPLEMENTS; DOUBLE-BLIND METHOD; FEMALE; HUMANS; INCIDENCE; MALE; MIDDLE AGED; ODDS RATIO; RISK FACTORS; SELENIUM; SKIN NEOPLASMS; TREATMENT FAILURE; UNITED STATES;

EID: 0141651873     PISSN: 00278874     EISSN: None     Source Type: Journal    
DOI: 10.1093/jnci/djg061     Document Type: Article

References (39)

1. Clark LC, Combs GF Jr, Turnbull BW, Slate EH, Chalker DK, Chow J, et al. Effects of selenium supplementation for cancer prevention in patients with carcinoma of the skin. A randomized controlled trial. Nutritional Prevention of Cancer Study Group. JAMA 1996;276:1957-63.
2. Duffield-Lillico AJ, Reid ME, Turnbull BW, Combs GF Jr, Slate EH, Fischbach LA, et al. Baseline characteristics and the effect of selenium supplementation on cancer incidence in a randomized clinical trial: a summary report of the nutritional prevention of cancer trial. Cancer Epidemiol Biomarkers Prev 2002;11:630-9.
3. Olson OE, Palmer IS, Cary EE. Modification of the official fluorometric method for selenium in plants. JAOAC 1975;58:117-26.
4. Clark LC, Graham GF, Crounse RG, Grimson R, Hulka B, Shy CM. Plasma selenium and skin neoplasms: a case-control study. Nutr Cancer 1984;6:13-21.
5. Clark LC, Graham GF, Bray J, Turnbull BW, Hulka BS, Shy CM. Nonmelanoma skin cancer and plasma selenium: a prospective cohort study. In: Combs GF Jr, Spallholz JE, Levander OA, Oldfield JE, editors. Selenium in biology and medicine, Part B. Third International Symposium; 1984 May 27-Jun 1; Beijing (The People's Republic of China). New York (NY): AVI Publishing Co.; 1987. p. 1122-34.
6. McShane LM, Clark LC, Combs GF Jr, Turnbull BW. Reporting the accuracy of biochemical measurements for epidemiologic and nutrition studies. Am J Clin Nutr 1991; 53:1354-60.
7. Lawless JF. Negative binomial and mixed Poisson regression. Can J Stat 1987;15: 209-25.
8. Clark LC, Graham GF, Crounse RG, Grimson R, Hulka B, Shy CM. Plasma selenium and skin neoplasms: a case-control study. Nutr Cancer 1984;6:13-21.
9. Clark LC, Graham GF, Turnbull BW, Bray J, Hulka B, Shy CM. Non-melanoma skin cancer and plasma selenium: a prospective cohort study. In: Combs GF Jr, Spallholz JE, Levander OA, Oldfield JE, editors. The Third International Symposium on Selenium in Biology and Medicine; 1984 May 27-Jun 1; Beijing (The People's Republic of China). New York (NY): AVI Publishing Co.; 1987: 1122-34.
10. Breslow RA, Alberg AJ, Helzlsouer KJ, Bush TL, Norkus EP, Morris JS, et al. Serological precursors of cancer: malignant melanoma, basal and squamous cell skin cancer, and prediagnostic levels of retinol, betacarotene, lycopene, alpha-tocopherol, and selenium. Cancer Epidemiol Biomarkers Prev 1995;4:837-42.
11. Karagas MR, Greenberg ER, Nierenberg D, Stukel TA, Morris JS, Stevens MM, et al. Risk of squamous cell carcinoma of the skin in relation to plasma selenium, alphatocopherol, beta-carotene, and retinol: a nested case-control study. Cancer Epidemiol Biomarkers Prev 1997;6:25-9.
12. Burke KE, Burford RG, Combs GF Jr, French IW, Skeffington DR. The effect of topical L-selenomethionine on minimal erythema dose of ultraviolet irradiation in humans. Photodermatol Photoimmunol Photomed 1992;9:52-7.
13. Oh SH, Park KK, Kim SY, Lee KJ, Lee YH. Evaluation of chemopreventive effect of dietary selenium-rich egg on mouse skin tumor induced by 2′-(4-nitrophenoxy)oxirane and 12-o-tetradecanoylphorbol-13-acetate. Carcinogenesis 1995;16:2995-8.
14. Overvad K, Thorling EB, Bjerring P, Ebbesen P. Selenium inhibits UV-light-induced skin carcinogenesis in hairless mice. Cancer Lett 1985;27:163-70.
15. Burke KE, Combs GF Jr, Gross EG, Bhuyan KC, Abu-Libdeh H. The effects of topical and oral L-selenomethionine on pigmentation and skin cancer induced by ultraviolet irradiation. Nutr Cancer 1992;17:123-37.
16. Pence BC, Delver E, Dunn DM. Effects of dietary selenium on UVB-induced skin carcinogenesis and epidermal antioxidant status. J Invest Dermatol 1994;102:759-61.
17. Stewart MS, Cameron GS, Pence BC. Anti-oxidant nutrients protect against UVB-induced oxidative damage to DNA of mouse keratinocytes in culture. J Invest Dermatol 1996;106:1086-9.
18. Rafferty TS, McKenzie RC, Hunter JA, Howie AF, Arthur JR, Nicol F, et al. Differential expression of selenoproteins by human skin cells and protection by selenium from UVB-radiation-induced cell death. Biochem J 1998;332:231-6.
19. Moysan A, Morliere P, Marquis I, Richard A, Dubertret L. Effects of selenium on UVA-induced lipid peroxidation in cultured human skin fibroblasts. Skin Pharmacol 1995;8: 139-48.
20. McKenzie RC. Selenium, ultraviolet radiation and the skin. Clin Exp Dermatol 2000; 25:631-6.
21. McKenzie RC, Arthur JR, Beckett GJ. Selenium and the regulation of cell signaling, growth, and survival: molecular and mechanistic aspects. Antioxid Redox Signal 2002; 4:339-51.
22. Rafferty TS, Walker C, Hunter JA, Beckett GJ, McKenzie RC. Inhibition of ultraviolet B radiation-induced interleukin 10 expression in murine keratinocytes by selenium compounds. Br J Dermatol 2002;146:485-9.
23. Frieling UM, Schaumberg DA, Kupper TS, Muntwyler J, Hennekens CH. A randomized, 12-year primary-prevention trial of beta carotene supplementation for nonmelanoma skin cancer in the Physician's Health Study. Arch Dermatol 2000;136:179-84.
24. Greenberg ER, Baron JA, Stukel TA, Stevens MM, Mandel JS, Spencer SK, et al. A clinical trial of beta carotene to prevent basal-cell and squamous-cell cancers of the skin. The Skin Cancer Prevention Study Group. N Engl J Med 1990;323:789-95.
25. Green A, Williams G, Neale R, Hart V, Leslie D, Parsons P, et al. Daily sunscreen application and beta carotene supplementation in prevention of basal-cell and squamous-cell carcinomas of the skin: a randomized controlled trial. Lancet 1999;354:723-9.
26. Levine N, Moon TE, Cartmel B, Bangert JL, Rodney S, Dong Q, et al. Trial of retinol and isotretinoin in skin cancer prevention: a randomized, double-blind, controlled trial. Southwest Skin Cancer Prevention Study Group. Cancer Epidemiol Biomarkers Prev 1997;6:957-61.
27. Tangrea JA, Edwards BK, Taylor PR, Hartman AM, Peck GL, Salasche SJ, et al. Long-term therapy with low-dose isotretinoin for prevention of basal cell carcinoma: a multicenter clinical trial. Isotretinoin-Basal Cell Carcinoma Study Group. J Natl Cancer Inst 1992;84:328-32.
28. Moon TE, Levine N, Cartmel B, Bangert JL, Rodney S, Dong Q, et al. Effect of retinol in preventing squamous cell skin cancer in moderate-risk subjects: a randomized, double-blind, controlled trial. Southwest Skin Cancer Prevention Study Group. Cancer Epidemiol Biomarkers Prev 1997;6:949-56.
29. Bavinck JN, Tieben LM, Van der Woude FJ, Tegzess AM, Hermans J, ter Schegget J, et al. Prevention of skin cancer and reduction of keratotic skin lesions during acitretin therapy in renal transplant recipients: a double-blind, placebo-controlled study. J Clin Oncol 1995;13:1933-8.
30. Einspahr JG, Stratton SP, Bowden GT, Alberts DS. Chemoprevention of human skin cancer. Crit Rev Oncol Hematol 2002;41: 269-85.
31. Kingston T, Gaskell S, Marks R. The effects of a novel potent oral retinoid (Rol3-6298) in the treatment of multiple solar keratoses and squamous cell epithelioma. Eur J Cancer Clin Oncol 1983;19:1201-5.
32. Kraemer KH, DiGiovanna JJ, Moshell AN, Tarone RE, Peck GL. Prevention of skin cancer in xeroderma pigmentosum with the use of oral isotretinoin. N Engl J Med 1988;318: 1633-7.
33. Hu G, Cassano PA. Antioxidant nutrients and pulmonary function: The Third National Health And Nutrition Examination Survey (NHANES III). Am J Epidemiol 2000;151: 975-81.
34. Pesch B, Ranft U, Jakubis P, Nieuwenhuijsen MJ, Hergemoller A, Unfried K, et al. Environmental arsenic exposure from a coal-burning power plant as a potential risk factor for nonmelanoma skin carcinoma: results from a case-control study in the district of Prievidza, Slovakia. Am J Epidemiol 2002; 155:798-809.
35. Tseng W, Chu H, How S, Fong J, Lin C, Yeh S. Prevalence of skin cancer in a endemic area of chronic arsenicism in Taiwan. J Natl Cancer Inst 1968;40:453-63.
36. Ip C, Ganther HE. Activity of methylated forms of selenium in cancer prevention. Cancer Res 1990;50:1206-11.
37. Styblo M, Thomas DJ. Selenium modifies the metabolism and toxicity of arsenic in primary rat hepatocytes. Toxicol Appl Pharmacol 2001;172:52-61.
38. Clark LC, Marshall JR. Randomized, controlled chemoprevention trials in populations at very high risk for prostate cancer: elevated prostate-specific antigen and high-grade prostatic intraepithelial neoplasia. Urology 2001;57(4 Suppl 1): 185-7.
39. Klein EA, Thompson IM, Lippman SM, Goodman PJ, Albanes D, Taylor PR, et al. SELECT: the next prostate cancer prevention trial. Selenium and vitamin E. J Urol 2001; 166:1311-15.